Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543777 · ClinicalTrials.gov registry record · Phase 1
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT00543777: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00543777 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00543777, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test the accuracy of magnetic resonance elastogram (MRE) and 2-point dixon magnetic resonance imaging (2PD MRI) using new computer software (called "phase correction algorithm") in patients who might have liver disease.
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Elastogram
- DIAGNOSTIC_TEST 2-Point Dixon Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2007-09 |
| Est. Completion | 2020-01-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00543777
The ClinicalTrials.gov registry entry for NCT00543777 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Elastogram is the first listed.
NCT00543777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00543777 about?
NCT00543777 is a clinical study titled "Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease". The goal of this clinical research study is to test the accuracy of magnetic resonance elastogram (MRE) and 2-point dixon magnetic resonance imaging (2PD MRI) using new computer software (called "phase correction algorithm") in patients who might have liver disease.
What is the current status of trial NCT00543777?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2007-09. Estimated completion is 2020-01-13.
What interventions are being tested in trial NCT00543777?
The interventions under investigation include: Magnetic Resonance Elastogram (DIAGNOSTIC_TEST), 2-Point Dixon Magnetic Resonance Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00543777?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.